a reputation for solving drug development challenges
Frontage helps organizations advance their early phase drug development efforts with extensive scientific and analytical services, including bioanalysis, preclinical, and Phase I-IIa studies and CMC product development. Our services and expert guidance span lead candidate identification in drug discovery through late stage clinical development. Biometrics capabilities support Phase I-IV clinical trials. CMC pharmaceutical development offerings range from organic synthesis to product commercialization support.
A deep understanding of drug development, combined with the skills and commitment to solve complex challenges reinforces our ability to deliver reliable data that provides informed decision making. We work with small and large molecules for novel biopharmaceuticals, as well as generic-equivalent and consumer products.
When you choose Frontage, we promise you a collaborative environment and a broad range of services and expertise delivered by skilled professionals. Our entire organization is geared toward flexibility and responsiveness.
Enroll in a Study | Current Studies | FAQ
> Frontage expands Bioanalytical Lab due to increased demand! See the press release HERE!
> Frontage appoints President of Clinical Services. See the press release HERE!
> Frontage announces the acquisition of BDM Consulting! See the announcement HERE!
Join Frontage at these upcoming
Trade Shows & Events:
CPSA in Langhorne, PA
● October 5-8, 2015
Site Solutions Summit in Amelia, FL
● October 8-11, 2015
ICSE in Madrid, Spain
● October 13-15, 2015
ISSX in Orlando, FL
● October 18-22, 2015
World ADC in San Diego, CA
● October 19-22, 2015
AAPS Annual Meeting in Orlando, FL
● October 25-29, 2015
EBF in Barcelona, Spain
● November 18-20, 2015